Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-10 1:26 pm Sale |
2022-01-07 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 3,722,294 7.836% |
-1,216,055 (-24.62%) |
Filing History |
| 2022-01-10 11:09 am Purchase |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
DRIEHAUS CAPITAL MANAGEMENT INC | 4,793,638 10.090% |
4,793,638 (New Position) |
Filing History |
| 2021-10-29 4:29 pm Purchase |
2021-10-21 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BIOTECHNOLOGY VALUE FUND L P | 3,003,879 6.500% |
3,003,879 (New Position) |
Filing History |
| 2021-04-22 5:56 pm Purchase |
2021-04-19 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Deep Track Capital, LP | 1,898,666 5.050% |
1,898,666 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
RA Capital Management, L.P. | 564,102 1.700% |
-1,311,107 (-69.92%) |
Filing History |
| 2021-02-16 06:31 am Purchase |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
5AM Ventures IV L.P. | 1,362,286 4.100% |
1,362,286 (New Position) |
Filing History |
| 2021-02-12 8:27 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Versant Venture Capital V L.P. | 1,895,002 5.800% |
-789,560 (-29.41%) |
Filing History |
| 2021-02-12 4:44 pm Purchase |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
ORBIMED ADVISORS LLC | 2,753,567 8.360% |
714,285 (+35.03%) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 1,819,600 5.500% |
-425,304 (-18.95%) |
Filing History |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 4,938,349 14.999% |
1,305,018 (+35.92%) |
Filing History |
| 2021-02-05 4:21 pm Purchase |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Struthers Richard Scott | 1,703,995 5.100% |
200,841 (+13.36%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BLACKROCK INC BLK |
2,113,195 6.400% |
2,113,195 (New Position) |
Filing History |
| 2020-06-11 5:06 pm Sale |
2019-06-10 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 2,244,904 6.800% |
-853,416 (-27.54%) |
Filing History |